The main market opportunities in the eosinophilic esophagitis pipeline include focusing on novel therapeutic approaches, potential development of first-in-class treatments like IRL201104, targeting ...
Everyday Health on MSN
Chronic Idiopathic Urticaria Treatment: Medication, Lifestyle Changes, and More
Treatment for chronic hives lasting at least 6 weeks may include one or more types of medication, as well as certain ...
Sanofi SNY reported third-quarter 2025 adjusted earnings of $1.70 per American depositary share, which beat the Zacks ...
Over the last 13 months, Sanofi and Regeneron have revved up the momentum for Dupixent, gaining three new indications for the ...
This article was originally published on www.si.com/high-school as The size of the fight in the Bulldog: Carl Junction senior ...
Health Canada has approved Dupixent® (dupilumab injection) as an add-on maintenance treatment in adult patients with chronic obstructive pulmonary disease (COPD) characterized by raised blood ...
Major financial institutions are demonstrating strong confidence in Celldex through substantial position increases during the second quarter. TD Asset Management aggressively expanded its holdings by ...
Approval based on WAYPOINT Phase III results demonstrating reduced nasal polyp severity and nasal congestion, near-elimination of the need for surgery and significantly reduced systematic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback